Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ)
Preprint posted on April 09, 2018 https://www.biorxiv.org/content/early/2018/04/09/297234
Article now published in Disease Models & Mechanisms at http://dx.doi.org/10.1242/dmm.034561
Zebrafish are proving themselves very useful as a model of complex pathologies, including melanoma. Researchers have generated numerous zebrafish transgenic melanoma model, which harbour mutations commonly found in human melanoma patients. These models are powerful tools that allow investigation into the molecular mechanisms behind melanoma, and crucially, into the discovery of drugs to target and kill cancerous cells.
These transgenic models are not perfect however, as often the timing and location of tumour formation can be quite variable, making monitoring of carcinogenesis amongst cohorts tricky. Tumour transplantation studies give more spatial and temporal control, but there is often a requirement to use immunosuppressed animals which may differ from immunocompetent fish in terms of the tumour microenvironment.
To address these problems, Callahan and colleagues have established a technique called TEAZ (Transgene Electroporation in Adult Zebrafish) in which different oncogenic transgenic constructs are electroporated directly into adult somatic tissue either simultaneously or sequentially to model melanoma.
TEAZ in a nutshell: plasmid DNA, in this case a ubb:tdTomato construct that will ubiquitously drive fluorescent protein expression, is injected into the adult zebrafish. Brief electrical pulses are applied to the anaesthetised fish to allow the plasmid to enter cells. The fluorescent protein is then observable using fluorescent microscopy. From Callahan et al., 2018 Figure 1a (under CC-BY-NC-ND 4.0)
- The authors first electroporated multiple constructs to drive fluorescent protein expression in defined regions of the zebrafish. Not only was fluorescence still stable after eight months, but cell type-specific transgene expression was achieved by using a melanocyte-specific reporter construct (mitfa:tdTomato).
- The team then took an existing melanoma model (mitfa:BRAFV600E;p53-/-;mitfa-/-), and electroporated in CRISPR-Cas9 elements to disrupt the tumour suppressor rb1. Strikingly, the electroporated animals developed melanotic lesions in just 3-7 weeks, compared to the 3-6 months taken for non-electroporated fish.
- These melanotic lesions were highly tumourigenic, and reminiscent of human high-grade melanoma. Histological analyses confirmed distant metastases in a range of locations – an event not documented with previous melanoma models.
- As proof-of-principle, the team electroporated mitfa:tdTomato into an existing tumour, in order to see if established tumours could be sequentially modified. In one week, cell-specific fluorescence could be observed within the tumour, suggesting that TEAZ could be used to model secondary mutations after tumour onset.
Why I chose this preprint
As someone in a zebrafish disease model lab, I often get a ‘lightbulb moment’ where I think of a great experiment, followed by a sinking feeling as I realise that it would only be made possible by using my fish’s great-grandchildren after rounds of painstaking genotyping. A way of introducing transgenes into an adult fish in any genetic background, and having spatial and temporal control of this could save labs so much time and reduce the numbers of fish required.
As our understanding of the molecular events behind cancer grows, it is important that our disease models reflect the nuances of human pathologies. Which genes drive tumour initiation vs tumour metastasis, and does the order of mutation acquisition matter? The thought of being able to reproducibly disrupt or repair genes in adult somatic cells using CRISPR, and to thereby screen for factors influencing tumour progression and metastasis is really exciting, and I look forward to seeing what this team and others do with TEAZ next. I also think TEAZ could be broadly useful as a quick way to introduce multiple fluorescent reporter constructs into a disease model, in order to image different subpopulations of cells in vivo within their microenvironment.
- The analysis of a tumour from an rb1 sgRNA-electroporated fish revealed the formation of a mixed histology sarcoma and melanoma tumour. The authors attributed this to using a ubiquitous instead of tissue-specific Cas9. As only two electroporated fish were used for this study, it might be important to find out how often these unexpected tumours occur in a larger cohort relative to more typical melanomas. If using a tissue-specific Cas9, the sgRNA and Cas9 might modify a much smaller proportion of cells, so it would be interesting to see if melanomas form to the same extent as when using ubiquitously-expressed Cas9.
- Perhaps related to the above, Callahan and colleagues sequenced these tumour cells and found two different mutations in 2% of rb1 alleles each. This was evidently more than enough to drive aggressive melanomas, but it will be interesting to see whether this frequency might be too low to make a biological difference when investigating other genes, or whether this mosaicism is in fact a good thing as it is more representative of a malignant subpopulation of cells within a tumour.
- Patton, E. E., et al. (2005). BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 15 , 249–254.
- Tang, Q., et al. (2016). Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat. Commun. 7 , 10358.
- Ceol, C. J., et al. (2011). The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471 , 513–517.
Posted on: 3rd May 2018 , updated on: 22nd June 2018Read preprint
Also in the cancer biology category:
Glycocalyx-mediated Cell Adhesion and Migration
|Selected by||Ankita Jha, Joseph Jose Thottacherry|
Viscoelastic relaxation of collagen networks provides a self-generated directional cue during collective migration
|Selected by||Mariana De Niz|
Podoplanin drives dedifferentiation and amoeboid invasion of melanoma
|Selected by||Ankita Jha|
Also in the genetics category:
A rapidly evolving actin mediates fertility and developmental tradeoffs in Drosophila
|Selected by||Hiral Shah, Gautam Dey|
Primary sex determination in chickens depends on DMRT1 dosage, but gonadal sex does not determine secondary sexual characteristics in adult birds
|Selected by||Martin Estermann|
Aberrant replication licensing drives Copy Number Gains across species
|Selected by||Yasmin Lau|
preListscancer biology category:in the
ASCB EMBO Annual Meeting 2019
A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)
|List by||Madhuja Samaddar, Ramona Jühlen, Amanda Haage, Laura McCormick, Maiko Kitaoka|
Lung Disease and Regeneration
This preprint list compiles highlights from the field of lung biology.
|List by||Rob Hynds|
Anticancer agents: Discovery and clinical use
Preprints that describe the discovery of anticancer agents and their clinical use. Includes both small molecules and macromolecules like biologics.
|List by||Zhang-He Goh|
Biophysical Society Annual Meeting 2019
Few of the preprints that were discussed in the recent BPS annual meeting at Baltimore, USA
|List by||Joseph Jose Thottacherry|
Also in the genetics category:
Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20
|List by||Maiko Kitaoka, Madhuja Samaddar, Miguel V. Almeida, Sejal Davla, Jennifer Ann Black, Gautam Dey|
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
|List by||Hiral Shah|
Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.
|List by||Sandra Malmgren Hill|
A compilation of cutting-edge research that uses the zebrafish as a model system to elucidate novel immunological mechanisms in health and disease.
|List by||Shikha Nayar|